These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36681209)

  • 1. Nanoparticle: A Promising Player in Nanomedicine and its Theranostic Applications for the Treatment of Cardiovascular Diseases.
    Saeed S; Ud Din SR; Khan SU; Gul R; Kiani FA; Wahab A; Zhong M
    Curr Probl Cardiol; 2023 May; 48(5):101599. PubMed ID: 36681209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases.
    Kim KS; Song CG; Kang PM
    Antioxid Redox Signal; 2019 Feb; 30(5):733-746. PubMed ID: 29228781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases.
    Wu Y; Vazquez-Prada KX; Liu Y; Whittaker AK; Zhang R; Ta HT
    Nanotheranostics; 2021; 5(4):499-514. PubMed ID: 34367883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine strategies for molecular targets with MRI and optical imaging.
    Pan D; Caruthers SD; Chen J; Winter PM; SenPan A; Schmieder AH; Wickline SA; Lanza GM
    Future Med Chem; 2010 Mar; 2(3):471-90. PubMed ID: 20485473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional role of nanoparticles for the diagnosis and therapeutics of cardiovascular diseases.
    Arshad I; Kanwal A; Zafar I; Unar A; Mouada H; Razia IT; Arif S; Ahsan M; Kamal MA; Rashid S; Khan KA; Sharma R
    Environ Res; 2024 Feb; 242():117795. PubMed ID: 38043894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.
    Mohamed NA; Marei I; Crovella S; Abou-Saleh H
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano revolution in cardiovascular health: Nanoparticles (NPs) as tiny titans for diagnosis and therapeutics.
    Abid J; Khalil FMA; Saeed S; Khan SU; Iqbal I; Khan SU; Anthony S; Shahzad R; Koerniati S; Naz F
    Curr Probl Cardiol; 2024 May; 49(5):102466. PubMed ID: 38369205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering.
    Shariati L; Esmaeili Y; Rahimmanesh I; Babolmorad S; Ziaei G; Hasan A; Boshtam M; Makvandi P
    Environ Res; 2023 Dec; 238(Pt 1):116933. PubMed ID: 37652218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
    Sahoo RK; Singh H; Thakur K; Gupta U; Goyal AK
    Curr Pharm Des; 2022; 28(2):91-103. PubMed ID: 34218771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic nanoparticles for cancer and cardiovascular applications.
    Wang D; Lin B; Ai H
    Pharm Res; 2014 Jun; 31(6):1390-406. PubMed ID: 24595494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine: A great boon for cardiac regenerative medicine.
    Choudhury P; Kandula N; Kosuru R; Adena SKR
    Eur J Pharmacol; 2024 Nov; 982():176969. PubMed ID: 39218342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.
    Godin B; Sakamoto JH; Serda RE; Grattoni A; Bouamrani A; Ferrari M
    Trends Pharmacol Sci; 2010 May; 31(5):199-205. PubMed ID: 20172613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances on nanoparticle-based therapies for cardiovascular diseases.
    Soumya RS; Raghu KG
    J Cardiol; 2023 Jan; 81(1):10-18. PubMed ID: 35210166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.
    Pala R; Anju VT; Dyavaiah M; Busi S; Nauli SM
    Int J Nanomedicine; 2020; 15():3741-3769. PubMed ID: 32547026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advancement in the Treatment of Cardiovascular Diseases: Conventional Therapy to Nanotechnology.
    Behera SS; Pramanik K; Nayak MK
    Curr Pharm Des; 2015; 21(30):4479-97. PubMed ID: 26278923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer's Disease: A State-of-the-Art (2017-2020).
    Binda A; Murano C; Rivolta I
    Int J Nanomedicine; 2020; 15():6113-6135. PubMed ID: 32884267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle Based Treatment for Cardiovascular Diseases.
    Gupta P; Garcia E; Sarkar A; Kapoor S; Rafiq K; Chand HS; Jayant RD
    Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):33-44. PubMed ID: 29737265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advancements in nanotechnology based drug delivery for the management of cardiovascular disease.
    Ullah A; Ullah M; Lim SI
    Curr Probl Cardiol; 2024 Apr; 49(4):102396. PubMed ID: 38266693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bio-inspired nanomaterials as novel options for the treatment of cardiovascular disease.
    Bose RJ; Ha K; McCarthy JR
    Drug Discov Today; 2021 May; 26(5):1200-1211. PubMed ID: 33561512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cutting edge nano-strategies to address old long-standing complications in cardiovascular diseases. A comprehensive review.
    Tesoro L; Hernandez I; Saura M; Badimón L; Zaragoza C
    Eur J Clin Invest; 2024 Jul; 54(7):e14208. PubMed ID: 38622800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.